Navigation Links
Cervical Cancer Vaccine Approved for Use

Medicines Safety Authority Medsafe has approved the use of Gardasil, cervical cancer vaccine on Thursday. Several health professionals are calling for its use in a national// immunization program.

The vaccine is said to offer immunity against four strains of Human Papilloma Virus (HPV) which is a common sexually transmitted infection. Although HPV infects about half of sexually active adults sometime during their life, it is usually harmless. However, it can cause the development of abnormal cells in the cervix lining, which can turn cancerous.

Presently Gardasil is recommended for use from ages 9 to 26, before women become sexually active and is expected to eventually included in the national immunization schedule.

Still Medsafe says women will need to have regular pap smears because of limited protection, besides which it is not known how long the vaccine will last.

According to Biopharmaceutical company CSI Limited Gardasil will be available in New Zealand in September.

The vaccine will have to be included in the Ministry of Health's national immunization program before its nationwide implementation. However the next review of its schedule isn't due until 2008.

Dr Dynes McConnell, from the Royal Australasian College of Obstetricians and Gynaecologists has warned for the need for action before then. She says that New Zealand will face a risk of falling behind if the vaccine is not introduced on a national level within the next one to three years.

Each year around 180 women are diagnosed with cervical cancer in New Zealand and around 60 die from the disease.


'"/>




Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy
10. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
11. HPV Vaccines for Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
Breaking Medicine Technology: